Shawn E R Schiller

This inventor holds 30 USPTO granted patents and 4 EPO patents, primarily in Pharmaceutical Compositions. Top assignees: Forma Therapeutics, Inc., Foghorn Therapeutics Inc., Valo Early Discovery, Inc.. Active years: 2016-2026.

USPTO Granted Patents = 30

% Patents Active = 53.3

EPO Patents = 4 (Patent Applications = 5)

Average Co-Inventor Count = 7.4

ph-index = 6

Forward Citations = 128(Granted Patents)

Location History:

Watertown, MA (US) (2019 - 2021)
Haverhill, MA (US) (2016 - 2023)

Company Filing History:

20 out of 125

Forma Therapeutics, Inc.

patents

6 out of 26

Foghorn Therapeutics Inc.

patents

2 out of 15

Valo Early Discovery, Inc.

Years Active: 2016-2026

Loading Chart...

Areas of Expertise:

Pharmaceutical Compositions

CBP Inhibitors

BET Bromodomain Inhibitors

FASN Inhibition

Thienopyrazine

Thienopyridine

Tetrahydroquinoline

Benzopiperazine

Deubiquitinase

CREB Binding Protein

Imidazo Quinoline

Ubiquitin-Specific Protease

30 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12649737 - Compounds and uses thereof (2026-06-09),

2. 12509453 - BRM/BRG1 inhibitors and uses thereof (2025-12-30),

3. 12441726 - Compounds and uses thereof (2025-10-14),

4. 12383560 - Compounds and uses thereof (2025-08-12),

5. 12378242 - Inhibiting CREB binding protein (CBP) (2025-08-05),

6. 12351577 - Inhibiting cyclic AMP-responsive element-binding protein (CREB) (2025-07-08),

7. 12252490 - Inhibiting deubiquitinase USP25 and USP28 (2025-03-18),

8. 12139487 - Compounds and uses thereof (2024-11-12),

9. 11787803 - Tetrahydro-imidazo quinoline compositions as CBP/P300 inhibitors (2023-10-17),

10. 11497752 - Compounds and uses thereof (2022-11-15),

11. 11325917 - Thienopyrazine carboxamides as ubiquitin-specific protease inhibitors (2022-05-10),

12. 11292791 - Tetrahydro-imidazo quinoline compositions as CBP/P300 inhibitors (2022-04-05),

13. 11267805 - Solid forms of (4-(2-fluoro-4-(1-methyl-1H-benzo[d]imidazol-5-yl)benzoyl) piperazine-1-yl)(1-hydroxycyclopropyl)methanone (2022-03-08),

14. 11254674 - Inhibiting CREB binding protein (CBP) (2022-02-22),

15. 11111229 - Tetrahydroquinoline compositions as BET bromodomain inhibitors (2021-09-07),

Title: The Innovative Journey of Shawn E R Schiller

Introduction: Shawn E R Schiller is a distinguished inventor based in Haverhill, MA, known for his groundbreaking contributions to the field of technology and innovation.

Latest Patents: Shawn E R Schiller holds several patents in various technological domains, showcasing his versatility and ingenuity in creating novel solutions for complex problems.

Career Highlights: With a career spanning over two decades, Shawn E R Schiller has consistently pushed the boundaries of innovation, leading to the development of cutting-edge technologies that have revolutionized industries.

Collaborations: Throughout his career, Shawn E R Schiller has collaborated with leading research institutions, universities, and tech companies, fostering a culture of innovation and knowledge sharing.

Conclusion: Shawn E R Schiller's passion for innovation and his relentless pursuit of excellence continue to inspire the next generation of inventors and technologists, leaving an indelible mark on the world of technology.